ArticleScientific reports2024

A genetic study to identify pathogenic mechanisms and drug targets for benign prostatic hyperplasia: a multi-omics Mendelian randomization study.

Bohan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.